Nivolumab as Second-Line Therapy Improves Survival in Patients with Unresectable Hepatocellular Carcinoma von Sanai, Faisal M, Odah, Hassan O, Alshammari, Kanan, Alzanbagi, Adnan, Alsubhi, Murooj, Tamim, Hani, Alolayan, Ashwaq, Alshehri, Ahmed, Alqahtani, Saleh A

Volltext